Biofrontera Inc. ( BFRI) - Key Metrics
BFRI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.93 | -$0.05 | -$0.13 | -$0.13 |
| 2026Q1 | $0.86 | -$0.41 | -$0.01 | -$0.01 |
| 2025Q4 | $1.47 | $0.48 | -$0.20 | -$0.20 |
| 2025Q3 | $0.65 | -$0.62 | -$0.35 | -$0.35 |
| 2025Q2 | $0.97 | -$0.57 | -$0.33 | -$0.33 |
BFRI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.73 |
| 2026Q1 | 0% | -0.49 |
| 2025Q4 | 0% | 0.30 |
| 2025Q3 | 0% | -0.40 |
| 2025Q2 | 0% | -0.31 |
BFRI
Price: $0.93
52 week price:
Earnings Per Share: -0.43 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 345400
Market Capitalization: 11.9 million